BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11906615)

  • 21. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
    Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
    Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.
    Levy I; Sherman M;
    Gut; 2002 Jun; 50(6):881-5. PubMed ID: 12010894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma.
    Li Q; Xing H; Liu D; Li H
    World J Surg Oncol; 2015 Oct; 13():294. PubMed ID: 26444667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization.
    Kim NH; Lee T; Cho YK; Kim BI; Kim HJ
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1397-1406. PubMed ID: 29314222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Classifications and prognosis of hepatocellular carcinoma].
    Krŭstev N; Grigorov N; Dinkov L; Donov M; Berberova M; Mendizova A; Stoĭnov S
    Khirurgiia (Sofiia); 2002; 58(1):11-4. PubMed ID: 12515027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of cirrhosis on long-term outcomes after liver resection in patients with a single small hepatocellular carcinoma].
    Liang BY; Huang ZY; Liu YA; Hou P; Ji GB; Chen XP
    Zhonghua Wai Ke Za Zhi; 2012 Oct; 50(10):865-9. PubMed ID: 23302452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An independent evaluation of modern prognostic scores in a central European cohort of 120 patients with hepatocellular carcinoma.
    Rabe C; Lenz M; Schmitz V; Pilz T; Fimmers R; Sauerbruch T; Caselmann WH
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1305-15. PubMed ID: 14624154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
    Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
    Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.
    Georgiades CS; Liapi E; Frangakis C; Park JU; Kim HW; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2006 Oct; 17(10):1619-24. PubMed ID: 17057003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
    Mazzanti R; Arena U; Pantaleo P; Antonuzzo L; Cipriani G; Neri B; Giordano C; Lanini F; Marchetti S; Gentilini P
    Can J Gastroenterol; 2004 Oct; 18(10):611-8. PubMed ID: 15497001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
    Lewin M; Gelu-Simeon M; Ostos M; Boufassa F; Sobesky R; Teicher E; Meyer L; Fontaine H; Salmon-Céron D; Samuel D; Seror O; Trinchet JC; Duclos-Vallée JC
    Radiology; 2015 Nov; 277(2):443-53. PubMed ID: 25961631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
    Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and prognostic factors in patients with hepatocellular carcinoma.
    Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
    Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma.
    Chang CY; Hsieh WY; Chau GY; Chen PH; Su CW; Hou MC; Lei HJ; Huo TI; Huang YH; Lin HC; Wu JC
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1368-1377. PubMed ID: 29994873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.